Nektar Therapeutics Analyst Ratings
BenzingaMar 6 22:43
Jefferies Maintains Hold on Nektar Therapeutics, Raises Price Target to $1
BenzingaMar 6 22:44
Jefferies Adjusts Nektar Therapeutics Price Target to $1 From $0.50, Maintains Hold Rating
MT NewswiresMar 6 01:49
Nektar Therapeutics Analyst Ratings
BenzingaNov 20, 2023 21:28
Nektar Therapeutics Analyst Ratings
BenzingaNov 9, 2023 22:17
Analysts Have Conflicting Sentiments on These Healthcare Companies: Arcus Biosciences (RCUS), Aligos Therapeutics (ALGS) and Nektar Therapeutics (NKTR)
TipRanksNov 8, 2023 14:22
Nektar Therapeutics (NKTR) Gets a Sell From Bank of America Securities
TipRanksSep 14, 2023 19:36
Nektar Therapeutics Analyst Ratings
BenzingaAug 8, 2023 00:29
Mizuho Securities Sticks to Their Hold Rating for Nektar Therapeutics (NKTR)
TipRanksAug 7, 2023 22:05
SVB Securities Sticks to Its Hold Rating for Nektar Therapeutics (NKTR)
TipRanksMay 12, 2023 00:47
Jefferies Upgrades Nektar Therapeutics (NKTR) to a Hold
TipRanksMay 10, 2023 16:36
Mizuho Securities Sticks to Its Hold Rating for Nektar Therapeutics (NKTR)
TipRanksMay 10, 2023 11:16
SVB Securities Reaffirms Their Hold Rating on Nektar Therapeutics (NKTR)
TipRanksMay 1, 2023 23:01
Mizuho Securities Reaffirms Their Hold Rating on Nektar Therapeutics (NKTR)
TipRanksApr 28, 2023 05:35
SVB Securities Sticks to Its Hold Rating for Nektar Therapeutics (NKTR)
TipRanksApr 19, 2023 14:03
Goldman Sachs Remains a Sell on Nektar Therapeutics (NKTR)
TipRanksApr 18, 2023 09:07
Analyst Ratings for Nektar Therapeutics
BenzingaMar 7, 2023 04:05
Oppenheimer Adjusts Nektar Therapeutics Price Target to $3 From $5, Maintains Perform Rating
MT NewswiresMar 6, 2023 22:02
Nektar Therapeutics (NKTR) Receives a Hold From Oppenheimer
TipRanksMar 6, 2023 20:26
Oppenheimer Maintains Perform on Nektar Therapeutics, Lowers Price Target to $3
BenzingaMar 6, 2023 20:20
No Data
No Data